• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Deoxyribonuclease-1-like 1 (DNASE1L1)

ACP23142

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP23142 Target NameDNASE1L1
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range19-302Protein LengthFull Length of Mature Protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP49184
Background Information
  • Uniprot Id

    P49184

  • Target Species

    Human

  • Target Name

    DNASE1L1

  • Target Full Name

    Deoxyribonuclease-1-like 1

  • Target Subcellular Location

    Endoplasmic reticulum.

  • Target Protein Families

    DNase I family

  • Target Tissue Specificity

    Highest levels in skeletal and cardiac muscles. Detectable in all other tissues tested except brain.

  • Target Synonyms

    Deoxyribonuclease I-like 1; Deoxyribonuclease-1-like 1; DNAS1L1; DNase I like 1; DNase I like muscle specific; DNase I lysosomal like; DNase I-like 1; DNase X; DNASE1L1; DNASEX; DNL1L; DNSL1_HUMAN; Muscle specific DNase I like; Muscle-specific DNase I-like; XIB

  • Target Background

    This gene encodes a deoxyribonuclease protein that shows high sequence similarity to DNase I. The encoded protein is localized to the endoplasmic reticulum and modified by N-linked glycosylation. Alternate transcriptional splice variants encoding the same protein have been observed.

Inquire Recombinant Human Deoxyribonuclease-1-like 1 (DNASE1L1) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification